176 related articles for article (PubMed ID: 36399692)
1. Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality.
Dee EC; Taunk NK; Chino FL; Deville C; McClelland S; Muralidhar V; McBride SN; Gillespie EF; Yamoah K; Nguyen PL; Mahal BA; Winkfield KM; Vapiwala N; Santos PMG
JCO Oncol Pract; 2023 Feb; 19(2):e197-e212. PubMed ID: 36399692
[TBL] [Abstract][Full Text] [Related]
2. Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting.
Patel TA; Jain B; Cho HL; Corti C; Vapiwala N; Chino F; Leeman JE; Dee EC
Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):183-192. PubMed ID: 38184401
[TBL] [Abstract][Full Text] [Related]
3. Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer.
Dee EC; Muralidhar V; Arega MA; Kishan AU; Spratt DE; Dess RT; King MT; Sha ST; Santos PMG; Butler SS; Sanford NN; Nguyen PL; Mahal BA
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1279-1285. PubMed ID: 33276019
[TBL] [Abstract][Full Text] [Related]
4. Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer.
Qureshy SA; Diven MA; Ma X; Marciscano AE; Hu JC; McClure TD; Barbieri C; Nagar H
JAMA Netw Open; 2023 Oct; 6(10):e2337165. PubMed ID: 37815829
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Patterns of Conventional Versus Stereotactic Body Radiotherapy in the Treatment of Spine Metastasis in the United States.
Kim E; McClelland S; Jaboin JJ; Attia A
J Palliat Care; 2021 Apr; 36(2):130-134. PubMed ID: 33356987
[TBL] [Abstract][Full Text] [Related]
6. Racial variation in receipt of quality radiation therapy for prostate cancer.
Lee DJ; Zhao Z; Huang LC; Koyoma T; Resnick MJ; Penson DF; Barocas DA; Hoffman KE
Cancer Causes Control; 2018 Oct; 29(10):895-899. PubMed ID: 30099628
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH; Tree AC; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Chan A; Dayes IS; Henderson D; Brown S; Cruickshank C; Burnett S; Duffton A; Griffin C; Hinder V; Morrison K; Naismith O; Hall E; van As N;
Lancet Oncol; 2019 Nov; 20(11):1531-1543. PubMed ID: 31540791
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in the use of SBRT for treating early-stage lung cancer.
Corso CD; Park HS; Kim AW; Yu JB; Husain Z; Decker RH
Lung Cancer; 2015 Aug; 89(2):133-8. PubMed ID: 26051446
[TBL] [Abstract][Full Text] [Related]
9. The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
Laucis AM; Jagsi R; Griffith KA; Dominello MM; Walker EM; Abu-Isa EI; Dilworth JT; Vicini F; Kocheril PG; Browne CH; Mietzel MA; Moran JM; Hayman JA; Pierce LJ;
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):949-958. PubMed ID: 32376311
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.
Johnson SB; Soulos PR; Shafman TD; Mantz CA; Dosoretz AP; Ross R; Finkelstein SE; Collins SP; Suy S; Brower JV; Ritter MA; King CR; Kupelian PA; Horwitz EM; Pollack A; Abramowitz MC; Hallman MA; Faria S; Gross CP; Yu JB
Radiother Oncol; 2016 Nov; 121(2):294-298. PubMed ID: 27890426
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer.
Patel SA; Switchenko JM; Fischer-Valuck B; Zhang C; Rose BS; Chen RC; Jani AB; Royce TJ
Radiat Oncol; 2020 Sep; 15(1):217. PubMed ID: 32933541
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Keating NL; Kouri E; He Y; Weeks JC; Winer EP
Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008
[TBL] [Abstract][Full Text] [Related]
13. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
[TBL] [Abstract][Full Text] [Related]
14. Travel distance and stereotactic body radiotherapy for localized prostate cancer.
Mahal BA; Chen YW; Sethi RV; Padilla OA; Yang DD; Chavez J; Muralidhar V; Hu JC; Feng FY; Hoffman KE; Martin NE; Spratt DE; Yu JB; Orio PF; Nguyen PL
Cancer; 2018 Mar; 124(6):1141-1149. PubMed ID: 29231964
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionation for clinically localized prostate cancer.
Hickey BE; James ML; Daly T; Soh FY; Jeffery M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
[TBL] [Abstract][Full Text] [Related]
16. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.
Phuong C; Chan JW; Ni L; Wall P; Mohamad O; Wong AC; Hsu IC; Chang AJ
Radiat Oncol; 2022 Jan; 17(1):12. PubMed ID: 35057827
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy Deserts: The Impact of Race, Poverty, and the Rural-Urban Continuum on Density of Providers and the Use of Radiation Therapy in the US.
LaVigne AW; DeWeese TL; Wright JL; Deville C; Yegnasubramanian S; Alcorn SR
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):17-27. PubMed ID: 36736631
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
19. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
20. Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer.
Yu JB; Sun Y; Jia AY; Vince RA; Shoag JE; Zaorsky NG; Spratt DE
JAMA Oncol; 2023 Dec; 9(12):1696-1701. PubMed ID: 37796479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
